[Topical use of inorganic mercury compounds].
Merk
H F
HF
Universitäts-Hautklinik, Köln.
D000287:Administration, Topical; D000641:Ammonia / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D003872:Dermatitis / Q000097:blood / Q000188:drug therapy*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D008627:Mercuric Chloride / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D008628:Mercury / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D008630:Mercury Poisoning / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D012869:Skin Absorption / Q000187:drug effects / Q000502:physiology; D013447:Sulfites / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics
D003879:Dermatologic Agents; D013447:Sulfites; D008627:Mercuric Chloride; D000641:Ammonia; D008628:Mercury; C028431:mercuric chloride, ammoniated
Topische Anwendung anorganischer Quecksilberverbindungen.